We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
-10.64%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$15.9B
AUM Growth
+$1.74B
Cap. Flow
+$3.32B
Cap. Flow %
20.89%
Top 10 Hldgs %
25.45%
Holding
1,202
New
361
Increased
299
Reduced
251
Closed
239

Top Buys

Rank Stock Value
1
BMNR
BitMine Immersion Technologies
BMNR
+$345M
2
AVGO icon
Broadcom
AVGO
+$265M
3
IREN icon
Iris Energy
IREN
+$230M
4
TSLA icon
Tesla
TSLA
+$215M
5
ORCL icon
Oracle
ORCL
+$210M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$324M
2
BKNG icon
Booking.com
BKNG
+$162M
3
MA icon
Mastercard
MA
+$89.6M
4
NOW icon
ServiceNow
NOW
+$60.5M
5
NFLX icon
Netflix
NFLX
+$59.9M

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Financials 9.37%
3 Consumer Discretionary 6.21%
4 Communication Services 5.85%
5 Healthcare 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIV icon
776
F5
FFIV
$22.1B
$247K ﹤0.01%
966
+25
+3% +$6.73K
MET icon
777
MetLife
MET
$61B
$246K ﹤0.01%
+3,112
New +$246K
QNST icon
778
QuinStreet
QNST
$870M
$244K ﹤0.01%
+17,000
New +$245K
GIL icon
779
Gildan
GIL
$9.25B
$244K ﹤0.01%
+3,907
New +$232K
BBY icon
780
Best Buy
BBY
$18B
$244K ﹤0.01%
+3,641
New +$278K
AG icon
781
First Majestic Silver
AG
$8.05B
$243K ﹤0.01%
14,598
-16,084
-52% -$223K
RNAM
782
DELISTED
Avidity Biosciences
RNAM
$243K ﹤0.01%
3,371
-48,629
-94% -$3.14M
NWL icon
783
Newell Brands
NWL
$2.16B
$242K ﹤0.01%
65,006
+45,006
+225% +$182K
WSM icon
784
Williams-Sonoma
WSM
$26.7B
$241K ﹤0.01%
1,350
+47
+4% +$8.81K
EEM icon
785
iShares MSCI Emerging Markets ETF
EEM
$28B
$241K ﹤0.01%
+4,404
New +$240K
MBLY icon
786
Mobileye
MBLY
$2.03B
$240K ﹤0.01%
23,000
SHAK icon
787
Shake Shack
SHAK
$2.3B
$239K ﹤0.01%
+2,944
New +$260K
CCIF
788
Carlyle Credit Income Fund
CCIF
$56.4M
$239K ﹤0.01%
+50,864
New +$260K
NVAX icon
789
Novavax
NVAX
$1.23B
$239K ﹤0.01%
35,494
+6,829
+24% +$51.5K
MSCI icon
790
MSCI
MSCI
$40B
$238K ﹤0.01%
+414
New +$232K
IDXX icon
791
Idexx Laboratories
IDXX
$42.9B
$237K ﹤0.01%
+350
New +$238K
PEGA icon
792
Pegasystems
PEGA
$4.41B
$235K ﹤0.01%
+3,933
New +$230K
CSGS
793
DELISTED
CSG Systems International
CSGS
$234K ﹤0.01%
+3,053
New +$225K
DXPE icon
794
DXP Enterprises
DXPE
$2.62B
$234K ﹤0.01%
+2,127
New +$232K
HRB icon
795
H&R Block
HRB
$5.18B
$232K ﹤0.01%
+5,317
New +$249K
BOE icon
796
BlackRock Enhanced Global Dividend Trust
BOE
$662M
$232K ﹤0.01%
19,781
+277
+1% +$3.21K
CNM icon
797
Core & Main
CNM
$8.17B
$231K ﹤0.01%
+4,441
New +$228K
WHR icon
798
Whirlpool
WHR
$2.42B
$231K ﹤0.01%
+3,197
New +$236K
CC icon
799
Chemours
CC
$2.59B
$230K ﹤0.01%
+19,531
New +$251K
MCD icon
800
McDonald's
MCD
$188B
$227K ﹤0.01%
744
-727
-49% -$223K

Similar funds

Marex Group's Q4 2025 Portfolio in Review

As of Q4 2025, Marex Group held 1,202 positions worth $15.9B, up 12% from $14.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Marex Group deployed $3.32B of net new capital in Q4 2025, opening 361 new positions and adding to 299 existing holdings. Its largest new stake was AdvisorShares Pure US Cannabis ETF: 6,900,000 shares worth $32.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Eli Lilly, an estimated $324M trimmed.

  • Marex Group's largest Q4 2025 buy was AdvisorShares Pure US Cannabis ETF: 6,900,000 shares worth $32.6M.
  • Marex Group added most to BitMine Immersion Technologies in Q4 2025, an estimated $345M increase.
  • Marex Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $324M.
  • Marex Group fully exited S&P Global in Q4 2025, selling an estimated $48.8M.
  • Marex Group's ten largest holdings make up 25% of its $15.9B portfolio in Q4 2025.
  • Marex Group opened 361 new positions and closed 239 in Q4 2025.
  • Marex Group's portfolio value rose 12% quarter-over-quarter to $15.9B.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.